KCNF1 inhibitors are a class of chemical compounds that specifically target the KCNF1 protein, a potassium voltage-gated channel subfamily F member 1. KCNF1 belongs to a group of ion channels that regulate the flow of potassium ions (K⁺) across the cell membrane, a crucial process for maintaining the cell's resting membrane potential and controlling electrical excitability. These channels play a pivotal role in various cellular processes, including nerve signal transmission, muscle contraction, and the regulation of heart rhythms. KCNF1 is particularly important in excitable tissues, where it contributes to the repolarization phase of action potentials, ensuring proper electrical activity in cells such as neurons and cardiac cells. Inhibitors of KCNF1 interfere with the channel's ability to conduct potassium ions, altering the electrical properties of the cells.
The mechanism of action of KCNF1 inhibitors involves blocking the potassium ion flow through the channel by binding to the pore or regulatory domains of the protein. This inhibition prevents KCNF1 from contributing to the cell's normal ion balance, which can affect cellular excitability and signaling. By reducing potassium ion permeability, these inhibitors can prolong or alter the action potentials in excitable cells, thereby modifying the cell's electrical activity. KCNF1 inhibitors are useful tools for studying the role of potassium channels in various physiological processes, such as neuronal signaling and cardiac rhythm regulation. Researchers use these inhibitors to gain insights into the specific contributions of KCNF1 to cellular electrical activity, exploring how potassium ion channels shape the excitability and function of electrically active tissues.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
4-Aminopyridine | 504-24-5 | sc-202421 sc-202421B sc-202421A | 25 g 1 kg 100 g | $37.00 $1132.00 $120.00 | 3 | |
Blocks voltage-gated potassium channels and could indirectly affect KCNF1 function by modifying membrane potential. | ||||||
Quinidine | 56-54-2 | sc-212614 | 10 g | $102.00 | 3 | |
A compound known to block several types of potassium channels, could indirectly modify KCNF1 activity. | ||||||
Haloperidol | 52-86-8 | sc-507512 | 5 g | $190.00 | ||
An antipsychotic known to block potassium channels, might have an indirect effect on KCNF1 channel function. | ||||||
Sotalol hydrochloride | 959-24-0 | sc-203699 sc-203699A | 10 mg 50 mg | $67.00 $246.00 | 3 | |
Beta-blocker known to inhibit potassium channels, could have an indirect effect on KCNF1 function. | ||||||